ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 31 filers reported holding ACER THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $20 | -13.0% | 24 | 0.0% | 0.00% | – |
Q2 2023 | $23 | +21.1% | 24 | 0.0% | 0.00% | – |
Q1 2023 | $19 | -68.3% | 24 | 0.0% | 0.00% | – |
Q4 2022 | $60 | – | 24 | 0.0% | 0.00% | – |
Q3 2022 | $0 | – | 24 | 0.0% | 0.00% | – |
Q2 2022 | $0 | – | 24 | 0.0% | 0.00% | – |
Q1 2022 | $0 | – | 24 | 0.0% | 0.00% | – |
Q4 2021 | $0 | – | 24 | 0.0% | 0.00% | – |
Q3 2021 | $0 | – | 24 | 0.0% | 0.00% | – |
Q2 2021 | $0 | – | 24 | 0.0% | 0.00% | – |
Q1 2021 | $0 | – | 24 | 0.0% | 0.00% | – |
Q4 2020 | $0 | – | 24 | 0.0% | 0.00% | – |
Q3 2020 | $0 | – | 24 | 0.0% | 0.00% | – |
Q2 2020 | $0 | – | 24 | 0.0% | 0.00% | – |
Q1 2020 | $0 | – | 24 | 0.0% | 0.00% | – |
Q4 2019 | $0 | – | 24 | 0.0% | 0.00% | – |
Q3 2019 | $0 | – | 24 | 0.0% | 0.00% | – |
Q2 2019 | $0 | -100.0% | 24 | 0.0% | 0.00% | – |
Q1 2019 | $1,000 | – | 24 | 0.0% | 0.00% | – |
Q4 2018 | $0 | -100.0% | 24 | 0.0% | 0.00% | – |
Q3 2018 | $1,000 | 0.0% | 24 | 0.0% | 0.00% | – |
Q2 2018 | $1,000 | – | 24 | 0.0% | 0.00% | – |
Q1 2018 | $0 | – | 24 | 0.0% | 0.00% | – |
Q4 2017 | $0 | – | 24 | 0.0% | 0.00% | – |
Q3 2017 | $0 | – | 24 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Worth Venture Partners, LLC | 250,518 | $722,000 | 0.59% |
Nantahala Capital Management | 990,655 | $2,853,000 | 0.09% |
GSA CAPITAL PARTNERS LLP | 82,421 | $237,000 | 0.04% |
FEDERATED HERMES, INC. | 117,673 | $339,000 | 0.00% |
BNP PARIBAS FINANCIAL MARKETS | 179 | $516,000 | 0.00% |
Horan Securities, Inc. | 24 | $0 | 0.00% |
OSAIC HOLDINGS, INC. | 200 | $1,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 3 | $0 | 0.00% |
WELLS FARGO & COMPANY/MN | 29 | $0 | 0.00% |
NORTHERN TRUST CORP | 31,083 | $90,000 | 0.00% |